Andropause, testosterone therapy, and quality of life in aging men

Cleveland Clinic Journal of Medicine

Volumn 67, Issue 12, 2000, Pages 880-882

  Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

AGED; AGING; ARTICLE; BONE DENSITY; CLIMACTERIUM; COGNITION; DIALYSIS; DRUG INDICATION; ENDURANCE; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; LIBIDO; MALE; MUSCLE MASS; RASH; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0033657814     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.67.12.880     Document Type: Article

References (17)

1. Morley JE, Kaiser FE, Perry HM 3rd, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metab Clin Exper 1997; 46:410-413.
2. Morley JE, Perry HM 3rd. Androgen deficiency in aging men: role of testosterone replacement therapy. J Lab Clin Med 2000; 135:370-378.
3. Tenover JL. Male hormone replacement therapy including "andropause." Endocrinol Metab Clin North Am 1998; 27:969-987.
4. Petak SM and the Hypogonadism Task Force. AACE Clinical Practice Guidelines for the Evaluation and Treatment of Hypogonadism in Adult Male Patients. 1998. Available at http://www.aace.com/clin/guides/ hypogonadism.html. Accessed 6/23/00.
5. Perry HM 3rd, Miller DK, Patrick P, Morley JE. Testosterone and leptin in older African-American men: relationship to age, strength, function, and season. Metab Clin Exper 2000; 49:1085-1091.
6. Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males (ADAM) [abstract]. Proc Am Endocrine Soc 1998; abstract P2-649.
7. US Food and Drug Administration Updates. Skin patch replaces testosterone. Food and Drug Administration Web Site. Available at: http://www.fda.gov. Accessed November 2, 2000.
8. Winters SJ. Current status of testosterone replacement therapy in men. Arch Fam Med 1999; 8:257-263.
9. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84:3666-3672.
10. Sih R, Morley JE, Kaiser FE, Perry HM 3rd, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 1997; 82:1661-1667.
11. Behre HM, Neischlag E. Comparative pharmacokinetics of testosterone esters. In: N Behre HM, Nieschlag E, editors. Testosterone: Action, Deficiency, Substitution. Berlin, Germany: Springer-Verlag; 1998:329-348.
12. Androderm product information. Physicians' Desk Reference. 54th ed. Montvale, NJ: Medical Economics Co; 2000:3170-3172.
13. Wang C, Berman N, Longstreth JA, et al. Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: A General Clinical Research Center Study. J Clin Endocrinol Metab 2000; 85:964-969.
14. Flood JF, Farr SA, Kaiser FE, La Regina M, Morley JE. Age-related decrease of plasma testosterone in SAMP8 mice: replacement improves age-related impairment of learning and memory. Physiol Behav 1995; 57:669-673.
15. Hartnell J, Korenman SG, Viosca SP. Results of testosterone enanthate therapy in older men. Proc 72nd Ann Meeting Endocrine Soc 1990:428.
16. Hajjar RR, Kaiser FE, Morley JE. Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin Endocrinol Metab 1997; 82:3793-3796.
17. Wu S, Weng X. Regulation of atrial natriuretic peptide, thromboxane, and prostaglandin production by androgen in elderly men with coronary heart disease. Chin Med Sci J 1993; 8:207-209.